{
  "id": 15835991,
  "title": "Natera director Jonathan Sheena sells $603,710 in company stock",
  "url": "https://urgent.news/2026/10/21/natera-director-jonathan-sheena-sells-603-710-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-21T02:01:02.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/natera-director-jonathan-sheena-sells-603710-in-company-stock-93CH-4961484"
  },
  "original_language": "en",
  "account": "On October 16, 2026, Jonathan Sheena, a director and co-founder of Natera, Inc. (NASDAQ: NTRA), sold 1,580 shares of the company's common stock, amounting to approximately $603,710. The trades occurred within a range of $398.9536 and $409.3575 per share. Adopting a Rule 10b5-1 trading plan on June 11, 2026, Sheena sold the shares indirectly for the benefit of the Caraluna 1 Trust and Caraluna 2 Trust, while disclaiming beneficial ownership. The sale took place as Natera stock approached its 52-week high of $437.41, having achieved a 117% return over the previous year. Analysts consider the stock overvalued relative to its Fair Value, classifying it among the most overvalued in the market. Natera, currently valued at $58.5 billion, has 13 ProTips available to subscribers. Post these transactions, Sheena personally owns 221,314 shares and indirectly holds 8,250 shares via each trust. Natera's second-quarter revenue exceeded market expectations, reporting $753 million against an anticipated $661.26 million, driven by business growth, full-year revenue guidance increase, and notable achievements like record test volume, enhanced margins, and regulatory approvals. Analysts, including RBC Capital and Rothschild Redburn, have raised their price targets and advised a Buy on Natera, citing its dominant position in minimal residual disease (MRD) testing and strong growth prospects.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}